These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36744397)

  • 1. Safety of medications for hereditary angioedema during pregnancy and lactation.
    Yeich A; Elhatw A; Ashoor Z; Park K; Craig T
    Expert Opin Drug Saf; 2023 Jan; 22(1):17-24. PubMed ID: 36744397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the long-term prevention of hereditary angioedema attacks.
    Beard N; Frese M; Smertina E; Mere P; Katelaris C; Mills K
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013403. PubMed ID: 36326435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of pregnancy in hereditary angioedema in a resource constrained setting: Our experience at Chandigarh, North India.
    Jindal AK; Barman P; Chawla S; Kaur A; Tyagi R; Sikka P; Chopra S; Mahajan S; Longhurst H; Singh S
    Immunobiology; 2022 Mar; 227(2):152175. PubMed ID: 35016112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian physician survey on the medical management of hereditary angioedema.
    Fu L; Kanani A; Lacuesta G; Waserman S; Betschel S
    Ann Allergy Asthma Immunol; 2018 Nov; 121(5):598-603. PubMed ID: 29958877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries.
    Guo Y; Zhang H; Lai H; Wang H; Chong-Neto HJ; Valle SOR; Zhu R
    Orphanet J Rare Dis; 2022 Nov; 17(1):399. PubMed ID: 36324138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hereditary angioedema: a review (CME).
    Bhardwaj N; Craig TJ
    Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term prophylaxis for children and adolescents with hereditary angioedema.
    Ajewole O; Lanlokun M; Dimanche S; Craig T
    Allergy Asthma Proc; 2021 May; 42(3):205-213. PubMed ID: 33980333
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Management of Hereditary Angioedema Attacks.
    Katelaris CH
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):541-556. PubMed ID: 28687108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Icatibant Safe for the Treatment of Hereditary Angioedema During Pregnancy?
    Šimac DV; Štimac T; Novak S
    Curr Allergy Asthma Rep; 2022 Oct; 22(10):135-140. PubMed ID: 36044174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of berotralstat for the treatment of hereditary angioedema.
    Farkas H; Balla Z
    Expert Rev Clin Immunol; 2023 Feb; 19(2):145-153. PubMed ID: 36408587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
    Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
    Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current medical management of hereditary angioedema: follow-up survey of US physicians.
    Riedl MA; Banerji A; Gower R
    J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
    Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
    Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on treatment of hereditary angioedema.
    Xu YY; Buyantseva LV; Agarwal NS; Olivieri K; Zhi YX; Craig TJ
    Clin Exp Allergy; 2013 Apr; 43(4):395-405. PubMed ID: 23517035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A; Caccia S; Cicardi M
    Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.